KEEP YOUR FINGER
ON THE PULSE

OF CONGESTIVE HEART FAILURE

The world's first miniature implant for left-atrial monitoring

The Advantage

Closed-loop CHF Therapy


VectoriousTM technology helps physicians to help patients help themselves. Via a simple, minimally-invasive implanted device, easy-to-access data and user-friendly external home-unit; the VectoriousTM system increases CHF patient quality of life and reduces readmission rates.

Daily 'push button' readings of patient hemodynamic pressure provide early, accurate physiological indication of cardiac decompensation. Patients enjoy ongoing, personalized care, physicians save lives and cut healthcare costs.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. GA811765.

The funding is to execute CE mark study in various sites across Europe.

This medical device is not available for sale within the United States or internationally

Let's talk more about VectoriousTM!